申请人:Hoffmann-La Roche Inc.
公开号:US04931463A1
公开(公告)日:1990-06-05
Racemic compounds of the formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and n are as described herein, enantiomers and diastereomers thereof, and salts of these esters with weak acids, are described. These compounds inhibit pancreas lipase and are useful agents in the treatment of obesity, hyperlipaemia, atherosclerosis and arteriosclerosis.
描述了公式##STR1##中的外消旋化合物,其中R.sup.1、R.sup.2、R.sup.3、R.sup.4、R.sup.5和n如本文所述,以及其对映体和非对映体,以及这些酯与弱酸盐。这些化合物抑制胰脂肪酶,是治疗肥胖、高脂血症、动脉粥样硬化和动脉硬化的有用药物。